表紙
市場調査レポート

世界の子宮頸がん検査市場および患者:ラップスメア、HPV DNA、VIA

Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide

発行 Renub Research 商品コード 298601
出版日 ページ情報 英文 232 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
世界の子宮頸がん検査市場および患者:ラップスメア、HPV DNA、VIA Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide
出版日: 2014年04月01日 ページ情報: 英文 232 Pages
概要

子宮頸がんは世界中の女性にとって死亡率の高い癌のひとつですが、パップスメア検査の幅広い利用により、過去数十年間で先進諸国における子宮頸がんの死亡率は大幅に減少しています。そのほか、HPV DNA・VIA検査も世界で一般的に用いられている検査です。VIA検査はパップスメア・HPV DNA検査と比較して費用が安いため、発展途上諸国で最も採用されている検査です。2013年における最大の子宮がん検査市場は米国となりました。その他の主要2カ国は、米国、ドイツおよび英国です。アジア地域では中国とインドが子宮頸がん検査人口を抱える上位2ヶ国となっています。

当レポートは、世界の子宮頸がん検査市場について調査し、子宮頸がん検査人口と予測、子宮頸がんの死亡率、検査別(ラップスメア・HPV DNA・VIA)の市場予測、および主要20カ国の市場予測などを提供しており、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 世界の子宮頸がん検査(スクリーニング)人口・予測

第3章 世界の子宮頸がん検査(スクリーニング)市場・予測

  • パップスメア検査(スクリーニング)市場・予測
  • HPV DNA検査(スクリーニング)市場・予測
  • 酢酸(VIA)検査(スクリーニング)による子宮頸がんの目視検査市場・予測

第4章 世界の子宮頸がん検査(スクリーニング)人口シェア・市場シェア・予測

  • 世界の子宮頸がん検査(スクリーニング)人口シェア・予測
  • 世界の子宮頸がん検査(スクリーニング)市場シェア・予測
  • 世界の子宮頸がんパップスメア検査(スクリーニング)市場シェア・予測
  • 世界の子宮頸がんHPV DNA検査(スクリーニング)市場シェア・予測
  • 世界の子宮頸がんVIA検査(スクリーニング)市場シェア・予測

第5章 英国

  • 子宮頸がん検査(スクリーニング)人口
    • パップスメア検査人口&予測
    • HPV DNA検査人口&予測
  • 子宮頸がん死亡率
  • 子宮頸がん検査(スクリーニング)分析
    • 子宮頸がん検査市場&予測
    • パップスメア検査市場・予測
    • HPV DNA検査市場・予測

第6章 フランス

第7章 ドイツ

第8章 イタリア

第9章 スペイン

第10章 スウェーデン

第11章 スイス

第12章 ノルウェー

第13章 オランダ

第14章 米国

第15章 カナダ

第16章 日本

第17章 韓国

第18章 シンガポール

第19章 マレーシア

第20章 オーストラリア

第21章 インド

第22章 中国

第23章 タイ

第24章 インドネシア

第25章 子宮頸がん市場の成長促進因子

第26章 子宮頸がん市場における課題

図表リスト

目次

Cervical cancer is one of the deadliest cancers among woman all over the world. However in the past few decades, mortality from cervical cancer has significantly decreased in developed countries due to widely use of Pap smear test. HPV DNA and VIA test are other popular tests used across world. VIA test is most adoptable test in developing countries as it is cheaper in comparison to Pap smear test and HPV DNA test.

Cervical cancer test market is dominated by United States in 2013. Germany and United Kingdom are other top two leaders in this market place. In Asian region, China and India are top two countries having largest cervical cancer test population. Few countries have also shown a decline in cervical cancer test market. However VIA test market accounts for largest share in cervical cancer test market in the case of developing countries like India and China.

A high prevalence of HPV-infected patients across the globe, rising incidences of teenage sexual cases, a rising number of organized cervical cancer programs initiated by governments and NGOs and introduction of low cost VIA test are some of the major growth drivers for the cervical cancer test market. However, lack of insufficient healthcare infrastructure and lack of cervical cancer screening awareness are the major hinder for cervical testing market.

Renub Research report titled " Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA - Test & Patients - Worldwide " provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 232 page report with 240 Figures and 14 Table provides a complete analysis of top 20 Countries Cervical Cancer Test Market & Population . All the 20 countries in the report have been studied from 3 viewpoints.

1. Cervical cancer Test Population (2007-2020)

  • Pap smear test population (2007-2020)
  • HPV DNA test population (2007-2020)
  • VIA test Population (2007-2020)

2. Cervical Cancer Mortality Population (2001-2011)

3. Cervical Cancer Test Market (2007-2020)

  • Pap smear test market (2007-2020)
  • HPV DNA test market (2007-2020)
  • VIA test market (2007-2020)

All the 20 Countries studied in the report are as follows

  • 1. United Kingdom
  • 2. France
  • 3. Germany
  • 4. Italy
  • 5. Spain
  • 6. Sweden
  • 7. Switzerland
  • 8. Norway
  • 9. Netherlands
  • 10. United States
  • 11. Canada
  • 12. Japan
  • 13. Korea
  • 14. Singapore
  • 15. Malaysia
  • 16. Australia
  • 17. India
  • 18. China
  • 19. Thailand
  • 20. Indonesia

Data Sources

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Table of Contents

1. Executive Summary

2. Worldwide Cervical Cancer Test (Screening) Population & Forecast

3. Worldwide Cervical Cancer Test (Screening) Market & Forecast

  • 3.1 Worldwide Cervical Cancer Pap Smear Test (Screening) Market & Forecast
  • 3.2 Worldwide Cervical Cancer HPV DNA Test (Screening) Market & Forecast
  • 3.3 Worldwide - Cervical Cancer Visual Inspection with Acetic Acid (VIA) Test (Screening) Market & Forecast

4. Worldwide Cervical Cancer Test (Screening) Population Share, Market Share & Forecast

  • 4.1 Worldwide Cervical Cancer Test (Screening) Population Share & Forecast
  • 4.2 Worldwide Cervical Cancer Test (Screening) Market Share & Forecast
  • 4.3 Worldwide Cervical Cancer Pap Smear Test (Screening) Market Share & Forecast
  • 4.4 Worldwide Cervical Cancer HPV DNA Test (Screening) Market Share & Forecast
  • 4.5 Worldwide Cervical Cancer VIA Test (Screening) Market Share & Forecast

5. United Kingdom - Cervical Cancer Test Analysis

  • 5.1 United Kingdom Cervical Cancer Test (Screening) Population
    • 5.1.1 United Kingdom Cervical Cancer Pap Smear Test Population & Forecast
    • 5.1.2 United Kingdom Cervical Cancer HPV DNA Test Population & Forecast
  • 5.2 United Kingdom Cervical Cancer Mortality
  • 5.3 United Kingdom Cervical Cancer Test (Screening) Analysis
    • 5.3.1 United Kingdom Cervical Cancer Test Market & Forecast
    • 5.3.2 United Kingdom Pap Smear Test Market & Forecast
    • 5.3.3 United Kingdom HPV DNA Test Market & Forecast

6. France - Cervical Cancer Test Analysis

  • 6.1 France Cervical Cancer Test (Screening) Population
    • 6.1.1 France Cervical Cancer Pap Smear Test Population & Forecast
    • 6.1.2 France Cervical Cancer HPV DNA Test Population & Forecast
  • 6.2 France Cervical Cancer Mortality
  • 6.3 France Cervical Cancer Test (Screening) Analysis
    • 6.3.1 France Cervical Cancer Test Market & Forecast
    • 6.3.2 France Pap Smear Test Market & Forecast
    • 6.3.3 France HPV DNA Test Market & Forecast

7. Germany - Cervical Cancer Test Analysis

  • 7.1 Germany Cervical Cancer Test (Screening) Population
    • 7.1.1 Germany Cervical Cancer Pap Smear Test Population & Forecast
    • 7.1.2 Germany Cervical Cancer HPV DNA Test Population & Forecast
  • 7.2 Germany Cervical Cancer Mortality
  • 7.3 Germany Cervical Cancer Test (Screening) Market
    • 7.3.1 Germany Cervical Cancer Test Market & Forecast
    • 7.3.2 Germany Pap Smear Test Market & Forecast
    • 7.3.3 Germany HPV DNA Test Market & Forecast

8. Italy - Cervical Cancer Test Analysis

  • 8.1 Italy Cervical Cancer Test (Screening) Population
    • 8.1.1 Italy Cervical Cancer Pap Smear Test Population & Forecast
    • 8.1.2 Italy Cervical Cancer HPV DNA Test Population & Forecast
  • 8.2 Italy Cervical Cancer Mortality
  • 8.3 Italy Cervical Cancer Test (Screening) Market
    • 8.3.1 Italy Cervical Cancer Test Market & Forecast
    • 8.3.2 Italy Pap Smear Test Market & Forecast
    • 8.3.3 Italy HPV DNA Test Market & Forecast

9. Spain - Cervical Cancer Test Analysis

  • 9.1 Spain Cervical Cancer Test (Screening) Population
    • 9.1.1 Spain Cervical Cancer Pap Smear Test Population & Forecast
    • 9.1.2 Spain Cervical Cancer HPV DNA Test Population & Forecast
  • 9.2 Spain Cervical Cancer Mortality
  • 9.3 Spain Cervical Cancer Test (Screening) Market
    • 9.3.1 Spain Cervical Cancer Test Market & Forecast
    • 9.3.2 Spain Pap Smear Test Market & Forecast
    • 9.3.3 Spain HPV DNA Test Market & Forecast

10. Sweden - Cervical Cancer Test Analysis

  • 10.1 Sweden Cervical Cancer Test (Screening) Population
    • 10.1.1 Sweden Cervical Cancer Pap Smear Test Population & Forecast
    • 10.1.2 Sweden Cervical Cancer HPV DNA Test Population & Forecast
  • 10.2 Sweden Cervical Cancer Mortality
  • 10.3 Sweden Cervical Cancer Test (Screening) Market
    • 10.3.1 Sweden Cervical Cancer Test Market & Forecast
    • 10.3.2 Sweden Pap Smear Test Market & Forecast
    • 10.3.3 Sweden HPV DNA Test Market & Forecast

11. Switzerland - Cervical Cancer Test Analysis

  • 11.1 Switzerland Cervical Cancer Test (Screening) Population
    • 11.1.1 Switzerland Cervical Cancer Pap Smear Test Population & Forecast
    • 11.1.2 Switzerland Cervical Cancer HPV DNA Test Population & Forecast
  • 11.2 Switzerland Cervical Cancer Mortality
  • 11.3 Switzerland Cervical Cancer Test (Screening) Market
    • 11.3.1 Switzerland Cervical Cancer Test Market & Forecast
    • 11.3.2 Switzerland Pap smear Test Market & Forecast
    • 11.3.3 Switzerland HPV DNA Test Market & Forecast

12. Norway - Cervical Cancer Test Analysis

  • 12.1 Norway Cervical Cancer Test (Screening) Population
    • 12.1.1 Norway Cervical Cancer Pap Smear Test Population & Forecast
    • 12.1.2 Norway Cervical Cancer HPV DNA Test Population & Forecast
  • 12.2 Norway Cervical Cancer Mortality
  • 12.3 Norway Cervical Cancer Test (Screening) Market
    • 12.3.1 Norway Cervical Cancer Test Market & Forecast
    • 12.3.2 Norway Pap Smear Test Market & Forecast
    • 12.3.3 Norway HPV DNA Test Market & Forecast

13. Netherlands - Cervical Cancer Test Analysis

  • 13.1 Netherlands Cervical Cancer Test (Screening) Population
    • 13.1.1 Netherlands Cervical Cancer Pap Smear Test Population & Forecast
    • 13.1.2 Netherlands Cervical Cancer HPV DNA Test Population & Forecast
  • 13.2 Netherlands Cervical Cancer Mortality
  • 13.3 Netherlands Cervical Cancer Test (Screening) Market
    • 13.3.1 Netherlands Cervical Cancer Test Market & Forecast
    • 13.3.2 Netherlands Pap Smear Test Market & Forecast
    • 13.3.3 Netherlands HPV DNA Test Market & Forecast

14. United States - Cervical Cancer Test Analysis

  • 14.1 United States Cervical Cancer Test (Screening) Population
    • 14.1.1 United States Cervical Cancer Pap Smear Test Population & Forecast
    • 14.1.2 United States Cervical Cancer HPV DNA Test Population & Forecast
  • 14.2 United States Cervical Cancer Mortality
  • 14.3 United States Cervical Cancer Test (Screening) Market
    • 14.3.1 United States Cervical Cancer Test Market & Forecast
    • 14.3.2 United States Pap smear Test Market & Forecast
    • 14.3.3 United States HPV DNA Test Market & Forecast

15. Canada - Cervical Cancer Test Analysis

  • 15.1 Canada Cervical Cancer Test (Screening) Population
    • 15.1.1 Canada Cervical Cancer Pap Smear Test Population & Forecast
    • 15.1.2 Canada Cervical Cancer HPV DNA Test Population & Forecast
  • 15.2 Canada Cervical Cancer Mortality
  • 15.3 Canada Cervical Cancer Test (Screening) Market
    • 15.3.1 Canada Cervical Cancer Test Market & Forecast
    • 15.3.2 Canada Pap Smear Test Market & Forecast
    • 15.3.3 Canada HPV DNA Test Market & Forecast

16. Japan - Cervical Cancer Test Analysis

  • 16.1 Japan Cervical Cancer Test (Screening) Population
    • 16.1.1 Japan Cervical Cancer Pap Smear Test Population & Forecast
    • 16.1.2 Japan Cervical Cancer HPV DNA Test Population & Forecast
  • 16.2 Japan Cervical Cancer Mortality
  • 16.3 Japan Cervical Cancer Test (Screening) Market
    • 16.3.1 Japan Cervical Cancer Test Market & Forecast
    • 16.3.2 Japan Pap Smear Test Market & Forecast
    • 16.3.3 Japan HPV DNA Test Market & Forecast

17. South Korea - Cervical Cancer Tests Analysis

  • 17.1 South Korea - Cervical Cancer Test (Screening) Population
    • 17.1.1 South Korea - Cervical Cancer Pap Smear Test Population & Forecast
    • 17.1.2 Korea Cervical Cancer HPV DNA Test Population & Forecast
  • 17.2 Korea Cervical Cancer Mortality
  • 17.3 Korea Cervical Cancer Test (Screening) Market
    • 17.3.1 Korea Cervical Cancer Test Market & Forecast
    • 17.3.2 Korea Pap Smear Test Market & Forecast
    • 17.3.3 Korea HPV DNA Test Market & Forecast

18. Singapore - Cervical Cancer Tests Analysis

  • 18.1 Singapore - Cervical Cancer Test (Screening) Population
    • 18.1.1 Singapore - Cervical Cancer Pap Smear Test Population & Forecast
    • 18.1.2 Singapore Cervical Cancer HPV DNA Test Population & Forecast
  • 18.2 Singapore Cervical Cancer Test (Screening) Market
    • 18.2.1 Singapore Cervical Cancer Test Market & Forecast
    • 18.2.2 Singapore Pap Smear Test Market & Forecast
    • 18.2.3 Singapore HPV DNA Test Market & Forecast

19. Malaysia - Cervical Cancer Test Analysis

  • 19.1 Malaysia - Cervical Cancer Test (Screening) Population
    • 19.1.1 Malaysia Cervical Cancer Pap Smear Test Population & Forecast
    • 19.1.2 Malaysia Cervical Cancer HPV DNA Test Population & Forecast
  • 19.2 Malaysia Cervical Cancer Test (Screening) Market
    • 19.2.1 Malaysia Cervical Cancer Test Market & Forecast
    • 19.2.2 Malaysia Pap Smear Test Market & Forecast
    • 19.2.3 Malaysia HPV DNA Test Market & Forecast

20. Australia - Cervical Cancer Test Analysis

  • 20.1 Australia - Cervical Cancer Test (Screening) Population
    • 20.1.1 Australia Cervical Cancer Pap Smear Test Population & Forecast
    • 20.1.2 Australia Cervical Cancer HPV DNA Test Population & Forecast
  • 20.2 Australia Cervical Cancer Mortality
  • 20.3 Australia Cervical Cancer Test (Screening) Market
    • 20.3.1 Australia Cervical Cancer Test Market & Forecast
    • 20.3.2 Australia Pap Smear Test Market & Forecast
    • 20.3.3 Australia HPV DNA Test Market & Forecast

21. India - Cervical Cancer Test Analysis

  • 21.1 India - Cervical Cancer Test (Screening) Population
    • 21.1.1 India Cervical Cancer Pap Smear Test Population & Forecast
    • 21.1.2 India Cervical Cancer HPV DNA Test Population & Forecast
    • 21.1.3 India Cervical Cancer VIA Test Population & Forecast
  • 21.2 India Cervical Cancer Test (Screening) Market
    • 21.2.1 India Cervical Cancer Test Market & Forecast
    • 21.2.2 India Pap Smear Test Market & Forecast
    • 21.2.3 India HPV DNA Test Market & Forecast
    • 21.2.4 India VIA Test Market & Forecast

22. China - Cervical Cancer Test Analysis

  • 22.1 China - Cervical Cancer Test (Screening) Population
    • 22.1.1 China Cervical Cancer Pap smear Test Population & Forecast
    • 22.1.2 China Cervical Cancer HPV DNA Test Population & Forecast
    • 22.1.3 China Cervical Cancer VIA Test Population & Forecast
  • 22.2 China - Cervical Cancer Test (Screening) Market
    • 22.2.1 China Cervical Cancer Test Market & Forecast
    • 22.2.2 China Pap Smear Test Market & Forecast
    • 22.2.3 China HPV DNA Test Market & Forecast
    • 22.2.4 China VIA Test Market & Forecast

23. Thailand - Cervical Cancer Test Analysis

  • 23.1 Thailand - Cervical Cancer Test (Screening) Population
    • 23.1.1 Thailand Cervical Cancer Pap Smear Test Population & Forecast
    • 23.1.2 Thailand Cervical Cancer VIA Test Population & Forecast
  • 23.2 Thailand Cervical Cancer Test (Screening) Market
    • 23.2.1 Thailand Cervical Cancer Test Market & Forecast
    • 23.2.2 Thailand Pap smear Test Market & Forecast
    • 23.2.3 Thailand VIA Test Market & Forecast

24. Indonesia - Cervical Cancer Test Analysis

  • 24.1 Indonesia Cervical Cancer Test (Screening) Population
    • 24.1.1 Indonesia Cervical Cancer Pap Smear Test Population & Forecast
    • 24.1.2 Indonesia Cervical Cancer HPV DNA Test Population & Forecast
    • 24.1.3 Indonesia Cervical Cancer VIA Test Population & Forecast
    • 24.1.4 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Population & Forecast
  • 24.2 Indonesia Cervical Cancer Test (Screening) Market
    • 24.2.1 Indonesia Cervical Cancer Test Market & Forecast
    • 24.2.2 Indonesia Pap smear Test Market & Forecast
    • 24.2.3 Indonesia HPV DNA Test Market & Forecast
    • 24.2.4 Indonesia VIA Test Market & Forecast
    • 24.2.5 Indonesia Cervical Cancer Both (Pap Smear & VIA) Test Market & Forecast

25. Cervical Cancer Test Market Growth Drivers

  • 25.1 Point No. 1
  • 25.2 Point No. 2
  • 25.3 Point No. 3

26. Challenges in Cervical Cancer Test Market

  • 26.1 Point No. 1
  • 26.2 Point No. 2

List of Figures:

  • Figure 2 1: Worldwide - Cervical Cancer Test Population (Million), 2005 - 2013
  • Figure 2 2: Worldwide - Forecast for Cervical Cancer Test Population (Million), 2014 - 2020
  • Figure 3 1: Worldwide - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 3 2: Worldwide - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 3 3: Worldwide - Cervical Cancer Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 3 4: Worldwide - Forecast for Cervical Cancer Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 3 5: Worldwide - Cervical Cancer HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 3 6: Worldwide - Forecast for Cervical Cancer HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 3 7: Worldwide - Cervical Cancer VIA Test Market (Million US$), 2005 - 2013
  • Figure 3 8: Worldwide - Forecast for Cervical Cancer VIA Test Market (Million US$), 2014 - 2020
  • Figure 5 1: United Kingdom - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 5 2: United Kingdom - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 5 3: United Kingdom - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 5 4: United Kingdom - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 5 5: United Kingdom - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 5 6: United Kingdom - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 5 7: United Kingdom - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 5 8: United Kingdom - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 5 9: United Kingdom - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 5 10: United Kingdom - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 5 11: United Kingdom - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 6 1: France - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 6 2: France - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 6 3: France - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 6 4: France - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 6 5: France - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 6 6: France - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 6 7: France - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 6 8: France - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 6 9: France - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 6 10: France - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 6 11: France - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 7 1: Germany - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 7 2: Germany - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 7 3: Germany - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 7 4: Germany - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 7 5: Germany - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 7 6: Germany - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 7 7: Germany - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 7 8: Germany - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 7 9: Germany - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 7 10: Germany - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 7 11: Germany - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 8 1: Italy - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 8 2: Italy - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 8 3: Italy - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 8 4: Italy - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 8 5: Italy - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 8 6: Italy - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 8 7: Italy - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 8 8: Italy - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 8 9: Italy - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 8 10: Italy - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 8 11: Italy - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 9 1: Spain - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 9 2: Spain - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 9 3: Spain - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 9 4: Spain - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 -2020
  • Figure 9 5: Spain - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 9 6: Spain - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 9 7: Spain - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 9 8: Spain - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 9 9: Spain - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 9 10: Spain - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 9 11: Spain - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 10 1: Sweden - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 10 2: Sweden - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 10 3: Sweden - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 10 4: Sweden - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 10 5: Sweden - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 10 6: Sweden - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 10 7: Sweden - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 10 8: Sweden - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 10 9: Sweden - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 10 10: Sweden - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 10 11: Sweden - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 11 1: Switzerland - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 11 2: Switzerland - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 11 3: Switzerland - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 11 4: Switzerland - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 11 5: Switzerland - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 11 6: Switzerland - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 11 7: Switzerland - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 11 8: Switzerland - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 11 9: Switzerland - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 11 10: Switzerland - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 11 11: Switzerland - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 12 1: Norway - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 12 2: Norway - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 12 3: Norway - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 12 4: Norway - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 12 5: Norway - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 12 6: Norway - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 12 7: Norway - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 12 8: Norway - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 12 9: Norway - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 12 10: Norway - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 12 11: Norway - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 13 1: Netherlands - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 13 2: Netherlands - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 13 3: Netherlands - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 13 4: Netherlands - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 13 5: Netherlands - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 13 6: Netherlands - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 13 7: Netherlands - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 13 8: Netherlands - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 13 9: Netherlands - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 13 10: Netherlands - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 13 11: Netherlands - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 14 1: United States - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 14 2: United States - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 14 3: United States - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 14 4: United States - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 14 5: United States - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 14 6: United States - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 14 7: United States - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 14 8: United States - Pap smear Test Market (Million US$), 2005 - 2013
  • Figure 14 9: United States - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 14 10: United States - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 14 11: United States - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 15 1: Canada - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 15 2: Canada - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 15 3: Canada - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 15 4: Canada - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 15 5: Canada - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 15 6: Canada - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 15 7: Canada - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 15 8: Canada - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 15 9: Canada - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 15 10: Canada - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 15 11: Canada - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 16 1: Japan - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 16 2: Japan - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 16 3: Japan - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 16 4: Japan - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 16 5: Japan - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 16 6: Japan - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 16 7: Japan - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 16 8: Japan - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 16 9: Japan - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 16 10: Japan - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 16 11: Japan - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 17 1: Korea - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 17 2: Korea - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 17 3: Korea - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 17 4: Korea - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 17 5: Korea - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 17 6: Korea - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 17 7: Korea - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 17 8: Korea - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 17 9: Korea - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 17 10: Korea - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 17 11: Korea - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 18 1: Singapore - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 18 2: Singapore - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 18 3: Singapore - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 18 4: Singapore - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 18 5: Singapore - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 18 6: Singapore - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 18 7: Singapore - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 18 8: Singapore - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 18 9: Singapore - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 18 10: Singapore - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 19 1: Malaysia - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 19 2: Malaysia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 19 3: Malaysia - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 19 4: Malaysia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 19 5: Malaysia - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 19 6: Malaysia - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 19 7: Malaysia - Pap smear Test Market (Million US$), 2005 - 2013
  • Figure 19 8: Malaysia - Forecast for Pap smear Test Market (Million US$), 2014 - 2020
  • Figure 19 9: Malaysia - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 19 10: Malaysia - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 20 1: Australia - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 20 2: Australia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 20 3: Australia - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 20 4: Australia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 20 5: Australia - Cervical Cancer Mortality (Number), 2001 - 2011
  • Figure 20 6: Australia - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 20 7: Australia - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 20 8: Australia - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 20 9: Australia - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 20 10: Australia - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 20 11: Australia - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 21 1: India - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 21 2: India - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 21 3: India - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 21 4: India - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 21 5: India - Cervical Cancer VIA Test Population (Thousand), 2005 - 2013
  • Figure 21 6: India - Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 - 2020
  • Figure 21 7: India - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 21 8: India - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 21 9: India - Pap smear Test Market (Million US$), 2005 - 2013
  • Figure 21 10: India - Forecast for Pap smear Test Market (Million US$), 2014 - 2020
  • Figure 21 11: India - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 21 12: India - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 21 13: India - VIA Test Market (Million US$), 2005 - 2013
  • Figure 21 14: India - Forecast for VIA Test Market (Million US$), 2014 - 2020
  • Figure 22 1: China - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 22 2: China - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 22 3: China - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 22 4: China - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 22 5: China - Cervical Cancer VIA Test Population (Thousand), 2005 - 2013
  • Figure 22 6: China - Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 - 2020
  • Figure 22 7: China - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 22 8: China - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 22 9: China - Pap smear Test Market (Million US$), 2005 - 2013
  • Figure 22 10: China - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 22 11: China - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 22 12: China - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 22 13: China - VIA Test Market (Million US$), 2005 - 2013
  • Figure 22 14: China - Forecast for VIA Test Market (Million US$), 2014 - 2020
  • Figure 23 1: Thailand - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 23 2: Thailand - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 23 3: Thailand - Cervical Cancer VIA Test Population (Thousand), 2005 - 2013
  • Figure 23 4: Thailand - Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 - 2020
  • Figure 23 5: Thailand - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 23 6: Thailand - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 23 7: Thailand - Pap smear Test Market (Million US$), 2005 - 2013
  • Figure 23 8: Thailand - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 23 9: Thailand - VIA Test Market (Million US$), 2005 - 2013
  • Figure 23 10: Thailand - Forecast for VIA Test Market (Million US$), 2014 - 2020
  • Figure 24 1: Indonesia - Cervical Cancer Pap Smear Test Population (Thousand), 2005 - 2013
  • Figure 24 2: Indonesia - Forecast for Cervical Cancer Pap Smear Test Population (Thousand), 2014 - 2020
  • Figure 24 3: Indonesia - Cervical Cancer HPV DNA Test Population (Thousand), 2005 - 2013
  • Figure 24 4: Indonesia - Forecast for Cervical Cancer HPV DNA Test Population (Thousand), 2014 - 2020
  • Figure 24 5: Indonesia - Cervical Cancer VIA Test Population (Thousand), 2005 - 2013
  • Figure 24 6: Indonesia - Forecast for Cervical Cancer VIA Test Population (Thousand), 2014 - 2020
  • Figure 24 7: Indonesia - Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2005 - 2013
  • Figure 24 8: Indonesia - Forecast for Cervical Cancer Both (Pap Smear & VIA) Test Population (Thousand), 2014 - 2020
  • Figure 24 9: Indonesia - Cervical Cancer Test Market (Million US$), 2005 - 2013
  • Figure 24 10: Indonesia - Forecast for Cervical Cancer Test Market (Million US$), 2014 - 2020
  • Figure 24 11: Indonesia - Pap Smear Test Market (Million US$), 2005 - 2013
  • Figure 24 12: Indonesia - Forecast for Pap Smear Test Market (Million US$), 2014 - 2020
  • Figure 24 13: Indonesia - HPV DNA Test Market (Million US$), 2005 - 2013
  • Figure 24 14: Indonesia - Forecast for HPV DNA Test Market (Million US$), 2014 - 2020
  • Figure 24 15: Indonesia - VIA Test Market (Million US$), 2005 - 2013
  • Figure 24 16: Indonesia - Forecast for VIA Test Market (Million US$), 2014 - 2020
  • Figure 24 17: Indonesia - Both (Pap smear & VIA) Test Market (Million US$), 2005 - 2013
  • Figure 24 18: Indonesia - Forecast for Both (Pap Smear & VIA) Test Market (Million US$), 2014 - 2020

List of Tables:

  • Table 4 1: Worldwide - Cervical Cancer Test Population Share (Percent), 2005 - 2013
  • Table 4 2: Worldwide - Forecast for Cervical Cancer Test Population Share (Percent), 2014 - 2020
  • Table 4 3: Worldwide - Cervical Cancer Test Market Share (Percent), 2005 - 2013
  • Table 4 4: Worldwide - Forecast for Cervical Cancer Test Market Share (Percent), 2014 - 2020
  • Table 4 5: Worldwide - Cervical Cancer Pap Smear Test Market Share (Percent), 2005 - 2013
  • Table 4 6: Worldwide - Forecast for Cervical Cancer Pap Smear Test Market Share (Percent), 2014 - 2020
  • Table 4 7: Worldwide - Cervical Cancer HPV DNA Test Market Share (Percent), 2005 - 2013
  • Table 4 8: Worldwide - Forecast for Cervical Cancer HPV DNA Test Market Share (Percent), 2014 - 2020
  • Table 4 9: Worldwide - Cervical Cancer VIA Test Market Share (Percent), 2005 - 2013
  • Table 4 10: Worldwide - Forecast for Cervical Cancer VIA Test Market Share (Percent), 2014 - 2020
  • Table 25 1: Worldwide - List of Countries which offer VIA Test via National Programs, 2010
  • Table 25 2: Worldwide - List of Countries which offer VIA Test via Pilot Programs, 2010
  • Table 25 3: Worldwide - Prevalence (Percent) of Young Women (15-44 Years) who Have Sex before the Age of 15 Years, 1994 - 2006
  • Table 25 4: Worldwide - HPV Prevalence (Percent) among Women with Normal Cervical Cytology, 2010
Back to Top